公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

1,001 记录

产品持有公司班级有效性
GLUC2, GLUCOSE HK10287410614ROCHE DIAGNÓSTICA BRASIL LTDAII现有
GLUC3 GLUCOSE HK10287410589ROCHE DIAGNÓSTICA BRASIL LTDAII现有
GLUC3(Glucose HK Gen.3)_cobas c10287411403ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Glucose Hemolyzing Reagent10287411704ROCHE DIAGNÓSTICA BRASIL LTDAI现有
GpIIbIIIa Antagonist Reagent10287410990ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HAPT2 (Tina-quant Haptoglobin ver.2_cobas c)10287411504ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HBDH OTIM10287410166ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HBDH2 (a-Hydroxybutyrate Dehydrogenase Gen.2)_cobas c10287411505ROCHE DIAGNÓSTICA BRASIL LTDAIII22/12/2035
HCYS (Homocysteine Enzymatic Assay)_cobas c10287411463ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HDLC4 (HDL-Cholesterol Gen.4)_cobas c10287411407ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HDLC4 - HDL-Cholesterol Gen.410287411354ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HIL Test10287411336ROCHE DIAGNÓSTICA BRASIL LTDAI现有
HITACHI REAGENTE HEMOLISANTE HBA1C10287410406ROCHE DIAGNÓSTICA BRASIL LTDAI现有
HIV combi PT Elecsyscobas e10287411765ROCHE DIAGNÓSTICA BRASIL LTDAIV13/10/2035
HSCRP (Tina-quant Cardiac high sensitivity CRP III)_cobas c10287411423ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HSV 1 and 2 Amplification/Detection Kit10287411069ROCHE DIAGNÓSTICA BRASIL LTDAIII03/11/2034
HSV 1 and 2 Controls and Cofactor Kit10287411066ROCHE DIAGNÓSTICA BRASIL LTDAIII03/11/2034
HbA1c Gen.3 - Hemoglobina A1c Gen. 310287410899ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Hemolyzing Reagent A1CD10287411133ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Hemolyzing Reagent Gen. 210287410683ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Herpes Simplex Vírus110287411089ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Homocysteine Calibrator Kit10287411006ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Homocysteine Control Kit10287411007ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Homocysteine Enzymatic Assay10287411008ROCHE DIAGNÓSTICA BRASIL LTDAII现有
HybClear Solution10287411485ROCHE DIAGNÓSTICA BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家